Skip to main content

Books in Pharmaceutical sciences

Elsevier's Pharmaceutical Sciences collection helps pharmaceutical scientists striving to optimize drug design and improve healthcare outcomes by offering comprehensive coverage of every aspect of drug development, integrating disciplines like organic chemistry, biology, and biotechnology. Focused on safety, efficacy, and formulation design, it includes specialized fields such as Clinical Pharmacology and Translational Research, providing valuable insights into the latest advancements in drug discovery.

    • Green Analytical Methods and Miniaturized Sample Preparation techniques for Forensic Drug Analysis

      • 1st Edition
      • October 22, 2024
      • Rajeev Jain + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 1 3 9 0 7 9
      • eBook
        9 7 8 0 4 4 3 1 3 9 0 6 2
      Green Analytical Methods and Miniaturized Sample Preparation techniques for Forensic Drug Analysis provides a comprehensive overview of GAMs in forensic drug analysis, including green sample preparation techniques, in-situ analytical platforms (such as DIC and µPADs), and on-site sample preparation. The book discusses not only eco-friendly GAM’s, but also methods which provide high sample throughput and cost-effective analysis, and are therefore of immense use in resource limited laboratories of developing countries. This is a comprehensive source of literature for analytical scientists in this developing area of sustainable and affordable analytical methods.
    • Technological Advances and Innovations in the Treatment of Chronic Respiratory Disorders

      • 1st Edition
      • October 21, 2024
      • Gabriele De Rubis + 5 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 7 3 4 5 2
      • eBook
        9 7 8 0 4 4 3 2 7 3 4 4 5
      Technological Advances and Innovations in the Treatment of Chronic Respiratory Disorders focuses on 3D printing, bioprinting, microfluidics, organ-on-a-chip systems, and molecular modeling. The book, written by a team of leading experts in the field, is an essential resource for anyone interested in the future of CRD treatment. Chapters discuss the emerging therapeutic approaches for CRDs, including biologicals and phytoceuticals. Core chapters of the book then cover the application of 3D printing, bioprinting, microfluidics, organ-on-a-chip systems, and molecular modeling to different CRDs. The book concludes with a discussion of the current clinical trials and future prospects for the management of CRDs.This is a valuable resource for researchers, clinicians, and other healthcare professionals who are interested in the latest technological advances in the field of CRDs. It will also be of interest to students and scientists working in the fields of pharmaceutical sciences, microfluidics, bioinformatics, drug design, drug delivery, and 3D printing.
    • Drug Discovery Stories

      • 1st Edition
      • October 18, 2024
      • Bin Yu + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 3 9 3 2 8
      • eBook
        9 7 8 0 4 4 3 2 3 9 3 3 5
      Drug Discovery Stories: From Bench to Bedside presents a collection of cases on the development of highly successful pharmaceuticals. It delves into the realm of drug discovery, exploring the structural biology and biological functions of the sought-after targets. The book covers the identification of promising compounds, their transformation from hits to leads through meticulous optimization, and the elucidation of how key compounds interact with the target (in essence, providing invaluable insights for drug design). Additionally, it covers essential information such as the pivotal biological and PK data of lead compounds, any noteworthy clinical results, and a comprehensive overview of other candidate compounds.The field of drug discovery and development has experienced rapid evolution, with numerous new drugs receiving approval each year. While several books have been published on this subject, there is a pressing need for a new book series that accurately reflects the current advancements in drug discovery. This book aims to not only cater to the drug discovery community but also engage other communities involved in chemical biology, synthetic chemistry, and pharmacology.
    • Theranostics Nanomaterials in Drug Delivery

      • 1st Edition
      • October 10, 2024
      • Prashant Kesharwani + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 2 0 4 4 9
      • eBook
        9 7 8 0 4 4 3 2 2 0 4 5 6
      Theranostics Nanomaterials in Drug Delivery presents the most recent advances in the development of theranostic nanomaterials for drug delivery. This book compiles reports and studies on the latest changes and improvements of theranostic nanocarriers such as nanoemulsions, liposomes, exosomes, polymeric micelles, PLGA nanoparticles, chitosan nanoparticles, dendrimer, quantum dots, silica nanoparticles, gold nanoparticles, silver nanoparticles, magnetic nanoparticles, and many more, all of which can help in the sensitive diagnosis, precise targeting, and efficient and controlled delivery of nanomaterials to control various diseases at different clinical stages.Theranostics nanomaterials in drug delivery will serve as a solid foundation and reference for pharmaceutical scientists, undergraduate and postgraduate students, researchers, and experts in the medical field involved in the development of advanced drug delivery systems.
    • Novel Drug Delivery Systems in the management of CNS Disorders

      • 1st Edition
      • September 27, 2024
      • Pooja A Chawla + 4 more
      • English
      • Paperback
        9 7 8 0 4 4 3 1 3 4 7 4 6
      • eBook
        9 7 8 0 4 4 3 1 3 4 7 5 3
      Novel Drug Delivery Systems in the Management of CNS Disorders offers a comprehensive source of information on delivering drugs to the central nervous system to treat various diseases and conditions. The book covers a wide range of CNS disorders, including epilepsy, Parkinson's, Alzheimer's, Huntington's, multiple sclerosis, schizophrenia, cerebral palsy, autism, ALS, and others.The book begins by presenting the foundations of drug delivery to the brain and addressing the associated challenges. It then delves into clinical trials and explores the future potential of the presented technologies.This reference is designed for drug delivery researchers in academia and corporations, providing them with the essential knowledge about overcoming the Brain-Blood Barrier and achieving targeted drug delivery to the central nervous system.
    • Artificial Intelligence for Drug Product Lifecycle Applications

      • 1st Edition
      • September 6, 2024
      • Alberto Pais + 3 more
      • English
      • Paperback
        9 7 8 0 3 2 3 9 1 8 1 9 0
      • eBook
        9 7 8 0 3 2 3 9 7 2 5 1 2
      Artificial Intelligence for Drug Product Lifecycle Applications explains the use of artificial intelligence (AI) in drug discovery and development paths, including the clinical and postapproval phases. This book gives methods for each of the drug development steps, from the fundamentals to postapproval drug product. AI is a synergistic assembly of enhanced optimization strategies with particular applications in pharmaceutical development and advanced tools for promoting cost-effectiveness throughout the drug lifecycle. Specifically, AI brings together the potential to improve drug approval rates, reduce development costs, get medications to patients faster, and help patients comply with their treatments.Accelerat... pharmaceutical development and drug product approval rates will enable larger profits from patent-protected market exclusivity. This book offers the tools and knowledge to create the right AI strategy to extend the landscape of AI applications across the drug lifecycle. It is especially useful for pharmaceutical scientists, health care professionals, and regulatory scientists, as well as advanced students and postgraduates actively involved in pharmaceutical product and process development involving the use of artificial intelligence in drug delivery applications.
    • Physico-Chemical Aspects of Dosage Forms and Biopharmaceutics

      • 1st Edition
      • August 9, 2024
      • Amit Kumar Nayak + 1 more
      • English
      • Paperback
        9 7 8 0 3 2 3 9 1 8 1 8 3
      • eBook
        9 7 8 0 3 2 3 9 7 2 4 7 5
      Physico-Chemical Aspects of Dosage Forms and Biopharmaceutics: Recent and Future Trends in Pharmaceutics, Volume Two explores aspects of pharmaceutics with an original approach that focuses on technology, novelties and future trends. The field of pharmaceutics is highly dynamic and rapidly expanding day-by-day, so it demands a variety of amplified efforts for designing and developing pharmaceutical processes and formulation strategies. Readers will find practical information for conducting research in pharmaceutics that is ideal for researchers in academia and industry as well as advanced graduate students in pharmaceutics.In addition, the book discusses the most recent developments in biopharmaceutics, including important and exciting areas such as solubility of drugs, pharmaceutical granulation, routes of drug administration, drug absorption, bioavailability and bioequivalence.
    • Design and Applications of Microneedles in Drug Delivery and Therapeutics

      • 1st Edition
      • June 28, 2024
      • Prashant Kesharwani
      • English
      • Paperback
        9 7 8 0 4 4 3 1 3 8 8 1 2
      • eBook
        9 7 8 0 4 4 3 1 3 8 8 0 5
      Design and Applications of Microneedles in Drug Delivery and Therapeutics details the design, characterization, and applications of this novel drug delivery system. Microneedles offer several advantages over traditional oral and parenteral approaches due to their ability to be fabricated and altered in shape, size and material type, and their convenience to be matched to specific treatment needs. This book covers the materials selection, design and fabrication approaches, and clinical translation of microneedles for a range of therapeutic applications, including cancer therapy, gene and vaccine delivery, wound healing, and more.This book is a forward-thinking resource for those working in the development of materials and devices for novel drug delivery.
    • Biochemical and Molecular Pharmacology in Drug Discovery

      • 1st Edition
      • June 26, 2024
      • Mithun Rudrapal + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 1 6 0 1 3 4
      • eBook
        9 7 8 0 4 4 3 1 6 0 1 4 1
      Biochemical and Molecular Pharmacology in Drug Discovery comprises fundamental biochemical and molecular aspects of drug discovery and basic understanding of modern drug discovery approaches, along with certain key topics related to molecular pharmacology of drugs and therapeutics. The book explains the phenomena of drug-target interactions, considering different biochemical systems and cellular strategies. With the advent of technologies, current advances, and research trends move toward molecular and/or target-based drug design and discovery. Through this book, readers will gain skills and knowledge with a thorough understanding of the subject of biochemical and molecular pharmacology in a comprehensive and systematic manner.Molecular pharmacology has gained significant momentum among researchers, scientists, and academicians because of its increasing interest in drug discovery research across the globe. Molecular pharmacology involves a fundamental understanding of drug actions at the molecular level with the help of several tools and techniques of biochemical and molecular biology.
    • Therapeutic Monoclonal Antibodies: From Lot Release to Stability Testing

      • 1st Edition
      • June 4, 2024
      • Harleen Kaur
      • English
      • Paperback
        9 7 8 0 3 2 3 9 0 6 0 0 5
      • eBook
        9 7 8 0 3 2 3 9 1 4 2 7 7
      Therapeutic Monoclonal Antibodies: From Lot Release to Stability Testing is a highly topical resource on a subject of interest for scientists and researchers working on monoclonal antibodies' characterization, release testing, stability testing and similarity assessments of monoclonal antibodies in the biopharmaceutical industry. Monoclonal antibodies (mAbs) are large, extremely complex and dynamic biomolecules, so it can be challenging to develop well-characterized therapeutic antibodies that meet regulatory expectations that are also in-line with commercialized standards for different drug markets.Lot release testing and understanding the stability of the mAb over a period of time, and in different environmental conditions, is an indispensable aspect of mAb physicochemical characterization. This book covers the process, including extensive analysis that starts with quantifying the purity attribute to glycan profiling and identifying the mAb primary structure. The book has a primary purpose of focusing on both Lot release testing and stability testing of monoclonal antibodies (subjects not covered in any great detail in other books).